BACKGROUND: No studies have compared first cardiovascular disease (CVD) events and non-CVD death between races in a competing risks framework, which examines risks for numerous events simultaneously. METHODS AND RESULTS: We used competing Cox models to estimate hazards for first CVD events and non-CVD death within and between races in 3 multicenter, National Heart, Lung, and Blood Institute-sponsored cohorts. Of 14 569 Atherosclerosis Risk in Communities (ARIC) study participants aged 45 to 64 years with mean follow-up of 10.5 years, 11.6% had CVD and 5.0% had non-CVD death as first events; among 4237 Cardiovascular Health Study (CHS) study participants aged 65 to 84 years and followed for 8.5 years, these figures were 43.2% and 15.7%, respectively. Middle-aged blacks were significantly more likely than whites to experience any CVD as a first event; this disparity disappeared by older adulthood and after adjustment for CVD risk factors. The pattern of results was similar for Multi-Ethnic Study of Atherosclerosis (MESA) participants. Traditional Cox and competing risks models yielded different results for coronary heart disease risk. Black men appeared somewhat more likely than white men to experience coronary heart disease with use of a standard Cox model (hazard ratio 1.06; 95% CI 0.90, 1.26), whereas they appeared less likely than white men to have a first coronary heart disease event with use of a competing risks model (hazard ratio, 0.77; 95% CI, 0.60, 1.00). CONCLUSIONS: CVD affects blacks at an earlier age than whites; this may be attributable in part to elevated CVD risk factor levels among blacks. Racial disparities in first CVD incidence disappear by older adulthood. Competing risks analyses may yield somewhat different results than traditional Cox models and provide a complementary approach to examining risks for first CVD events.
BACKGROUND: No studies have compared first cardiovascular disease (CVD) events and non-CVD death between races in a competing risks framework, which examines risks for numerous events simultaneously. METHODS AND RESULTS: We used competing Cox models to estimate hazards for first CVD events and non-CVD death within and between races in 3 multicenter, National Heart, Lung, and Blood Institute-sponsored cohorts. Of 14 569 Atherosclerosis Risk in Communities (ARIC) study participants aged 45 to 64 years with mean follow-up of 10.5 years, 11.6% had CVD and 5.0% had non-CVD death as first events; among 4237 Cardiovascular Health Study (CHS) study participants aged 65 to 84 years and followed for 8.5 years, these figures were 43.2% and 15.7%, respectively. Middle-aged blacks were significantly more likely than whites to experience any CVD as a first event; this disparity disappeared by older adulthood and after adjustment for CVD risk factors. The pattern of results was similar for Multi-Ethnic Study of Atherosclerosis (MESA) participants. Traditional Cox and competing risks models yielded different results for coronary heart disease risk. Black men appeared somewhat more likely than white men to experience coronary heart disease with use of a standard Cox model (hazard ratio 1.06; 95% CI 0.90, 1.26), whereas they appeared less likely than white men to have a first coronary heart disease event with use of a competing risks model (hazard ratio, 0.77; 95% CI, 0.60, 1.00). CONCLUSIONS: CVD affects blacks at an earlier age than whites; this may be attributable in part to elevated CVD risk factor levels among blacks. Racial disparities in first CVD incidence disappear by older adulthood. Competing risks analyses may yield somewhat different results than traditional Cox models and provide a complementary approach to examining risks for first CVD events.
Authors: D G Ives; A L Fitzpatrick; D E Bild; B M Psaty; L H Kuller; P M Crowley; R G Cruise; S Theroux Journal: Ann Epidemiol Date: 1995-07 Impact factor: 3.797
Authors: Diane E Bild; Robert Detrano; Do Peterson; Alan Guerci; Kiang Liu; Eyal Shahar; Pamela Ouyang; Sharon Jackson; Mohammed F Saad Journal: Circulation Date: 2005-03-15 Impact factor: 29.690
Authors: M E Gornick; P W Eggers; T W Reilly; R M Mentnech; L K Fitterman; L E Kucken; B C Vladeck Journal: N Engl J Med Date: 1996-09-12 Impact factor: 91.245
Authors: Robert Detrano; Alan D Guerci; J Jeffrey Carr; Diane E Bild; Gregory Burke; Aaron R Folsom; Kiang Liu; Steven Shea; Moyses Szklo; David A Bluemke; Daniel H O'Leary; Russell Tracy; Karol Watson; Nathan D Wong; Richard A Kronmal Journal: N Engl J Med Date: 2008-03-27 Impact factor: 91.245
Authors: Christopher J L Murray; Sandeep C Kulkarni; Catherine Michaud; Niels Tomijima; Maria T Bulzacchelli; Terrell J Iandiorio; Majid Ezzati Journal: PLoS Med Date: 2006-09 Impact factor: 11.069
Authors: John T Wilkins; Kunal N Karmali; Mark D Huffman; Norrina B Allen; Hongyan Ning; Jarett D Berry; Daniel B Garside; Alan Dyer; Donald M Lloyd-Jones Journal: Int J Epidemiol Date: 2015-08-14 Impact factor: 7.196
Authors: Paul A Nyquist; Murat S Bilgel; Rebecca Gottesman; Lisa R Yanek; Taryn F Moy; Lewis C Becker; Jennifer Cuzzocreo; Jerry Prince; David M Yousem; Diane M Becker; Brian G Kral; Dhananjay Vaidya Journal: Cerebrovasc Dis Date: 2014-03-25 Impact factor: 2.762
Authors: Stephen P Glasser; Daniel L Halberg; Charlie Sands; Christopher M Gamboa; Paul Muntner; Monika Safford Journal: Am J Hypertens Date: 2013-09-12 Impact factor: 2.689
Authors: Sydney A Jones; Latetia V Moore; Kari Moore; Melissa Zagorski; Shannon J Brines; Ana V Diez Roux; Kelly R Evenson Journal: Prev Med Date: 2015-06-09 Impact factor: 4.018
Authors: Inge I Bouwman; Marco H Blanker; Boris W V Schouten; Arthur M Bohnen; Rien J M Nijman; Wouter K van der Heide; J L H Ruud Bosch Journal: World J Urol Date: 2014-09-25 Impact factor: 4.226
Authors: Yutaka Tanami; Masahiro Jinzaki; Satoru Kishi; Matthew Matheson; Andrea L Vavere; Carlos E Rochitte; Marc Dewey; Marcus Y Chen; Melvin E Clouse; Christopher Cox; Sachio Kuribayashi; Joao A C Lima; Armin Arbab-Zadeh Journal: Circ Cardiovasc Imaging Date: 2015-03 Impact factor: 7.792